Do repeated anti-VEGF intravitreal injections accelerate glaucomatous progression?
There is no apparent association between repeated intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) agents in eyes with glaucoma spectrum diseases (GSD) and an acceleration of glaucomatous progression, according to a study. The study included 68 eyes from 34 patients with bilateral and similar GSD. One eye from...
Read MoreContact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved